Affiliation:
1. Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115, USA.
Abstract
The tumor suppressor WT1 represses and activates transcription. The loss and/or imbalance of the dual transcriptional activity of WT1 may contribute to Wilms' tumor. In this study, we identified par-4 (for prostate apoptosis response) as a WT1-interacting protein that itself functions as a transcriptional repressor. par-4 contains a putative leucine zipper domain and is specifically upregulated during apoptosis of prostate cells (S. F. Sells, D. P. Wood, Jr., S. S. Joshi-Barve, S. Muthukkumar, R. J. Jacob, S. A. Crist, S. Humphreys, and V. M. Rangnekar, Cell Growth Differ. 5:457-466, 1994). The leucine repeat domain of par-4 was shown to interact with the zinc finger DNA binding domain of WT1. Immunoprecipitation-Western blot (immunoblot) analyses demonstrated in vivo WT1-par-4 interactions. par-4 was ubiquitously expressed, and the protein was found in both the nucleus and the cytoplasm. Functionally, par-4 inhibited transcription activated by WT1, but not by the related protein EGR1. Inhibition of WT1-mediated transcription was dependent on the domain of par-4 that mediates its physical association with WT1. In addition, par-4 augmented WT1-mediated repression, possibly by contributing an additional repression domain. Consistent with these results, par-4 functioned as a transcriptional repressor when brought to a promoter via a heterologous DNA binding domain. Significantly, par-4, but not a mutant unable to interact with WT1, rescued growth suppression caused by WT1. Thus, we identified a novel repressor that modulates transcription as well as growth suppression functions of WT1.
Publisher
American Society for Microbiology
Subject
Cell Biology,Molecular Biology
Reference71 articles.
1. Identification of novel regions of deletion in familial Wilms tumor by comparative genomic hybridization;Altura R. A.;Cancer Res.,1996
2. The expression of the Wilms' tumour gene, WT1, in the developing mammalian embryo;Armstrong J. F.;Mech. Dev.,1992
3. Characterization of regions of chromosomes 12 and 16 involved in nephroblastoma tumorigenesis;Austruy E.;Genes Chromosomes Cancer,1995
4. Ausubel F. M. R. Brent R. E. Kingston D. D. Moore J. G. Seidman J. A. Smith and K. Struhl (ed.). 1993. Current protocols in molecular biology vol. 2. John Wiley & Sons Inc. New York.
5. Anaplastic Wilms' tumor, a subtype displaying poor prognosis, harbors p53 gene mutations;Bardeesy N.;Nat. Genet.,1994